▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3825 by analyst upside · 2026-08-13
VEEV
Veeva Systems Inc.
Healthcare · Market Cap $39B · P/E 42.9x
ANALYST PRICE TARGET
+1.1%
implied upside to consensus target
Current Price $241.51
Consensus Target $244.14
Bull Target $350.0
Bear Target $165.0
Analysts Covering 28
ANALYST CONSENSUS - BUY
Strong Buy
8
Buy
12
Hold
7
Sell
1
52-Week Low $148.05
52-Week High $310.5
YTD Return +10.0%
FUNDAMENTALS
Market Cap $39B
P/E Ratio (TTM) 42.9x
Forward P/E 24.1x
EPS (TTM) $5.63
PEG Ratio 1.06
Dividend Yield N/A
Revenue (TTM) $3.3B
Profit Margin 28.4%
52-WEEK RANGE
52-Week Low $148.05
52-Week High $310.5
Current Price $241.51
Bear Target $165.0
Bull Target $350.0
● Now $241.51 ● Target $244.14
TRADING DATA
Avg Volume 2.3M
YTD Return +10.0%
Analyst Count 28
Consensus Buy
Upside to Target +1.1%
Last Updated 2026-08-13

ANALYST SUMMARY

Veeva Systems Inc. (VEEV) is currently trading at $241.51 with a Wall Street consensus price target of $244.14, implying potential upside of 1.1% over the next 12 months. 28 analysts currently cover VEEV, with a consensus rating of Buy - 71% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $350.0, while the most cautious has a target of $165.0.

VEEV operates in the Healthcare sector with a market capitalisation of $39B. The stock is up 10.0% year-to-date and is currently trading near the upper end of its 52-week range of $148.05 – $310.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

DXCM +2.9%
DexCom, Inc.
$34B · P/E 35.3x · Buy
A +7.5%
Agilent Technologies, Inc.
$42B · P/E 30.0x · Buy
IQV +13.8%
IQVIA Holdings Inc.
$40B · P/E 30.3x · Buy
BDX +4.6%
Becton, Dickinson and Company
$50B · P/E 31.3x · Buy
TEVA +12.1%
Teva Pharmaceutical Industries Limited
$43B · P/E 61.2x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for VEEV, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup - Reiterated
Neutral → Neutral 2026-06-04 Building track record
Mizuho - Reiterated
Outperform → Outperform 2026-06-04 Building track record
Goldman Sachs - Reiterated
Sell → Sell 2026-06-04 Building track record
Oppenheimer reit
Outperform → Outperform 2026-06-04 14% win rate (7 calls)
Canaccord Genuity - Reiterated
Hold → Hold 2026-06-04 Building track record
Stifel - Reiterated
Buy → Buy 2026-06-04 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-06-04 Building track record
UBS - Reiterated
Neutral → Neutral 2026-06-04 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
55
out of 100
Coverage depth
26/30
Consensus clarity
15/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →